Comparison of effect of levonorgestrel intrauterine system vs tablet dienogest in adenomyosis
Phase 4
- Conditions
- Health Condition 1: N858- Other specified noninflammatory disorders of uterus
- Registration Number
- CTRI/2020/05/025186
- Lead Sponsor
- AII india institute of medical Sciences Bhubaneswar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age 20 years or more, Adenomyosis diagnosed by imaging
Exclusion Criteria
Ovarian endometriosis, or uterine leiomyoma diagnosed by imaging, severe anemia, Patients who are planned for hysterectomy or any other modality of treantment, Patients who want pregnancy in future, Patients with contraindication(s) to use LNG IUS or dienogest, PAtients not giviong conscent for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in visual analogue scale score for painTimepoint: 3 months
- Secondary Outcome Measures
Name Time Method Change in menstrual blood loss by subjective assessment, change in quality of life by WHO BREF questionnaire, to record adverse eventsTimepoint: 3 months